Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Badve

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Journal of Neuro-Oncology|January 7, 2015
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patientsRenata Duchnowska, Jacek Jassem, Chirayu Pankaj Goswami, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working groupElena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
Oncogene|April 5, 2005
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsBrent W Sutherland, Jill Kucab, Joyce Wu, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 29, 2012
Establishment and characterization of a novel cell line derived from human thymoma AB tumorYesim Gökmen-Polar, Kerry L Sanders, Chirayu P Goswami, et al.
Journal of the National Cancer Institute|May 4, 2013
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breastLawrence J Solin, Robert Gray, Frederick L Baehner, et al.
Frontiers in Oncology|September 25, 2023
Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapyChaitanyanand B Koppiker, Devaki A Kelkar, Madhura Kulkarni, et al.
JAMA Oncology|October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Journal of Neuro-Oncology|January 7, 2015
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patientsRenata Duchnowska, Jacek Jassem, Chirayu Pankaj Goswami, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working groupElena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
Oncogene|April 5, 2005
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsBrent W Sutherland, Jill Kucab, Joyce Wu, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 29, 2012
Establishment and characterization of a novel cell line derived from human thymoma AB tumorYesim Gökmen-Polar, Kerry L Sanders, Chirayu P Goswami, et al.
Journal of the National Cancer Institute|May 4, 2013
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breastLawrence J Solin, Robert Gray, Frederick L Baehner, et al.
Frontiers in Oncology|September 25, 2023
Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapyChaitanyanand B Koppiker, Devaki A Kelkar, Madhura Kulkarni, et al.
JAMA Oncology|October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Pageof 19